Avricore Health Inc (AVCR : TSX-V)
Common Stock
$0.06
CAD
+0.00 (9.09%)
Last updated: 2026-06-24
AVCR
Avricore Health Inc
WealthAwesomePerformance
1 Day
+9.09%
1 Week
+20.00%
1 Month
+0.00%
YTD
+9.09%
Key Statistics
Market Cap
$6.95M
52W High
$0.10
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.06
Beta
0.30
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/24/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 20,000 |
| 6/23/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 85,830 |
| 6/22/2026 | $0.04 | $0.06 | $0.04 | $0.06 | $0.06 | 23,393 |
| 6/19/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 6,000 |
| 6/17/2026 | $0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 4,000 |
| 6/16/2026 | $0.05 | $0.05 | $0.04 | $0.05 | $0.05 | 41,019 |
| 6/15/2026 | $0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 22,000 |
| 6/12/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 38,300 |
| 6/11/2026 | $0.05 | $0.06 | $0.05 | $0.06 | $0.06 | 8,000 |
| 6/10/2026 | $0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 37,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
121.4%
Annualized
90-Day Vol
111.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.09 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $144,138
- EBITDA
- $-1.29M
- Profit Margin
- 0.00%
- ROE (TTM)
- -184.99%
- EPS (Diluted)
- -0.02
- Book Value
- 0.00
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About AVCR
Articles Featuring AVCR.V
Latest articles and analysis covering AVCR.V
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc's stock has surged by over 9% today, driven by investor optimism surrounding its expansion plans in the UK. The company recently closed a significant financing round, positioning it for growth.
What to Expect from Avricore Health Inc.'s Earnings Report on May 29
Avricore Health Inc. is gearing up for its earnings report on May 29, with investors eager to see how recent expansions impact its financial health.
